riTUXimab
| Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RiTUXimab (Rituxan) | SOLUTION, INTRAVENOUS | 10 mg/mL (10 mL) | ||||||||||||||
| RiTUXimab (Rituxan) | SOLUTION, INTRAVENOUS | 10 mg/mL (50 mL) | ||||||||||||||
| RiTUXimab-abbs (Truxima) | SOLUTION, INTRAVENOUS | 10 mg/mL (10 mL) | ||||||||||||||
| RiTUXimab-abbs (Truxima) | SOLUTION, INTRAVENOUS | 10 mg/mL (50 mL) | ||||||||||||||
| RiTUXimab-pvvr (Ruxience) | SOLUTION, INTRAVENOUS | 10 mg/mL (10 mL) | ||||||||||||||
| RiTUXimab-pvvr (Ruxience) | SOLUTION, INTRAVENOUS | 10 mg/mL (50 mL) |
UNC Health
System Formulary Restriction:
Inpatient:
Outpatient:
Med Center
UNC Medical Center Formulary Restrictions
RiTUXimab for Treatment of Glomerular, Rheumatic or Auto-Immune Conditions, and Antibody Mediated Rejection Guideline
Pardee
RiTUXimab (Rituxan) Administration Procedure
Rex
Rex Hematology-Oncology Formulary Restrictions